Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.7 USD | +3.66% | -8.33% | -30.08% |
Mar. 27 | Transcript : GlycoMimetics, Inc., Q4 2023 Earnings Call, Mar 27, 2024 | |
Mar. 27 | GlycoMimetics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.08% | 106M | |
-2.17% | 103B | |
+1.79% | 95.28B | |
+2.04% | 22.15B | |
-16.25% | 21.02B | |
-8.70% | 18.15B | |
-41.01% | 16.73B | |
-13.33% | 16.05B | |
+4.61% | 13.68B | |
+34.17% | 12.17B |
- Stock Market
- Equities
- GLYC Stock
- News GlycoMimetics, Inc.
- HC Wainwright Adjusts GlycoMimetics Price Target to $13 From $14, Maintains Buy Rating